Immunocytochemistry and Cell Markers

Immunocytochemistry (ICC) is the application of antibody-based staining to cytologic preparations in order to detect specific protein antigens in or on cells. By revealing a cell's immunophenotype, it helps assign lineage, distinguish reactive from neoplastic processes, identify the primary site of a metastasis, and detect markers that morphology alone cannot show.

Definition

Immunocytochemistry is an ancillary technique in which labelled antibodies are used to localize specific protein antigens in cytologic preparations, generating an immunophenotypic profile that supplements morphologic diagnosis.

Scope

The entry covers the principle of antigen-antibody localization on smears, liquid-based preparations, cytospins, and cell blocks; the panels of markers used to address common diagnostic questions; and the pre-analytic and interpretive factors specific to cytologic material. It treats ICC as a methodological topic, not as a source of diagnostic protocols.

Core questions

• How does specimen preparation and fixation affect antigen preservation and staining quality in cytology?
• Which marker panels distinguish the principal differential diagnoses on a given cytologic sample?
• How should limited cytologic material be conserved so that an adequate immunopanel can be performed?

Key concepts

• Antigen-antibody binding and detection systems
• Cell block versus smear and liquid-based substrates
• Marker panels rather than single stains
• Lineage and site-of-origin markers
• Pre-analytic variables (fixation, processing)
• Validation of antibodies on cytologic substrates

Mechanisms

A primary antibody binds its target antigen in the fixed cytologic preparation, and the bound antibody is then visualized through a detection system that deposits a coloured chromogen or fluorophore at the antigen site. Because cytologic samples are prepared in diverse ways - air-dried or alcohol-fixed smears, liquid-based media, cytospins, and formalin-fixed cell blocks - antigen preservation and background staining vary with the substrate, so antibodies validated for histology cannot be assumed to behave identically on cytology. Interpretation relies on the pattern and distribution of staining across a panel of markers selected to resolve a specific differential, rather than on any single positive result.

Clinical relevance

Immunocytochemistry contributes to tumour classification, lineage assignment, and identification of the likely primary site of metastatic disease in cytologic samples. As reference content it describes how immunophenotypic information is generated and interpreted; choice of antibody panels and reporting are laboratory decisions and not individualized clinical advice.

Evidence & guidelines

Reviews of immunocytochemistry on cytologic material emphasize that results depend strongly on preparation and validation, and that markers should be applied as panels interpreted in morphologic context (Fetsch & Abati, 2001; Hirokawa et al., 2024). Substrate-specific validation is repeatedly stressed because antibody performance can differ between histologic sections and cytologic preparations.

History

Antibody-based localization, developed for tissue sections, was progressively adapted to cytology as detection chemistry and antigen-preservation methods improved. Effusion cytology was an early and influential proving ground, where panels were assembled to separate reactive mesothelial cells from metastatic carcinoma, a problem reviewed in detail by Fetsch and Abati (2001).

Debates

How transferable are histology-validated antibodies to cytologic substrates?

Because fixation and preparation differ across smears, liquid-based media, and cell blocks, antibody sensitivity and specificity may not carry over from tissue sections, so substrate-specific validation is advocated before clinical use.

Seminal works

• fetsch-abati-2001

Frequently asked questions

What is the difference between immunocytochemistry and immunohistochemistry?

Both use antibodies to localize antigens, but immunocytochemistry is applied to cytologic preparations such as smears, liquid-based slides, and cell blocks, whereas immunohistochemistry is applied to sections of tissue; the differing substrates require separate validation.

Why are markers used in panels rather than singly?

No single marker is fully specific, so a panel chosen to address a defined differential, and interpreted together with morphology, gives a more reliable immunophenotype than any individual stain.